RDGL — VIVOS INC
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1449349 ·
Last close
$0.06
Market Cap
$32.10M
52W High
$0.09
52W Low
$0.06
ADV30
1,065,684
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 36,068 | -8,018 | -545,492 | -1,184,845 | 2,950,505 | 2,525,782 | 253,195 |
| Dec 2025 | 24,752 | -3,105 | -1,095,719 | -1,078,514 | 1,867,583 | 1,558,525 | 206,743 |
| Sep 2025 | 1,879 | -12,815 | -531,023 | -507,294 | 2,295,185 | 2,202,109 | 112,693 |
| Jun 2025 | 15,000 | -34,753 | -674,772 | -645,513 | 2,775,556 | 2,660,590 | 96,458 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-2,032,406
Investing CF
$-151,205
Financing CF
$1,547,478
CapEx
$-151,205
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-89,612,091
Inventory
$56,863
Receivables
$7,668
ST Investments
—
EBIT TTM
$-2,847,006
Pretax Income TTM
$-3,416,166
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$77,699
EBITDA
—
Free Cash Flow
$-960,187
Enterprise Value
$39,036,660
Total Cash
$2,525,782
Total Debt
$109,593
Shares Out
493,890,608
Trailing EPS
$-0.01
Book Value
$-0.02
ROE
-116.1%
ROA
-56.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 68,379 | -3,165,047 | -3,066,017 | 1,867,583 | 206,743 | — | -2,057,743 |
| Dec 2024 | 27,995 | -2,604,384 | -2,910,448 | 2,233,456 | 86,209 | — | -1,684,039 |
| Dec 2023 | 19,500 | -2,793,146 | -2,894,753 | 1,610,124 | 245,004 | — | -1,293,023 |
| Dec 2022 | 36,499 | -2,517,749 | -2,470,161 | 1,742,736 | 81,692 | — | -1,120,058 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MLSS | MILESTONE SCIENTIFIC INC. | $30.83M | $0.35 | — |
| VASO | VASO Corp | $33.44M | $0.19 | — |
| NSPR | InspireMD, Inc. | $34.19M | $0.73 | — |
| PSTV | PLUS THERAPEUTICS, INC. | $34.49M | $5.01 | — |
| PETV | PetVivo Holdings, Inc. | $29.32M | $0.80 | — |
News headlines (Yahoo Finance, 1h cache)
Vivos Receives Washington Radioactive Materials License for IsoPet Manufacturing, Enabling Domestic Production Expansion (RDGL)
2026-06-11 14:51 · Yahoo
Vivos Therapeutics Plans to File for Proposed Rights Offering
2026-06-11 13:11 · Yahoo
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
2026-06-11 12:30 · Yahoo
Vivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® Manufacturing
2026-06-11 12:30 · Yahoo
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients
2026-06-10 13:03 · Yahoo
Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026
2026-06-08 17:39 · Yahoo
Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing
2026-06-05 12:45 · Yahoo
Vivos Inc. (OTCQB: RDGL) submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™
2026-06-05 12:30 · Yahoo
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update
2026-05-20 20:10 · Yahoo
Vivos Therapeutics Reports Full Year 2025 Financial Results
2026-04-15 20:20 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.